Tracy R. Daniels‐Wells

4.3k total citations · 2 hit papers
51 papers, 3.0k citations indexed

About

Tracy R. Daniels‐Wells is a scholar working on Radiology, Nuclear Medicine and Imaging, Molecular Biology and Hematology. According to data from OpenAlex, Tracy R. Daniels‐Wells has authored 51 papers receiving a total of 3.0k indexed citations (citations by other indexed papers that have themselves been cited), including 23 papers in Radiology, Nuclear Medicine and Imaging, 18 papers in Molecular Biology and 16 papers in Hematology. Recurrent topics in Tracy R. Daniels‐Wells's work include Monoclonal and Polyclonal Antibodies Research (23 papers), Multiple Myeloma Research and Treatments (8 papers) and Chronic Lymphocytic Leukemia Research (7 papers). Tracy R. Daniels‐Wells is often cited by papers focused on Monoclonal and Polyclonal Antibodies Research (23 papers), Multiple Myeloma Research and Treatments (8 papers) and Chronic Lymphocytic Leukemia Research (7 papers). Tracy R. Daniels‐Wells collaborates with scholars based in United States, Argentina and Mexico. Tracy R. Daniels‐Wells's co-authors include Manuel L. Penichet, Gustavo Helguera, Tracie Delgado, José Antonio Rodríguez, José A. Rodríguez, Lai Sum Leoh, Eggehard Holler, Julia Y. Ljubimova, Maggie Kozman and Carlos A. Casiano and has published in prestigious journals such as Nature Communications, Blood and The Journal of Immunology.

In The Last Decade

Tracy R. Daniels‐Wells

49 papers receiving 3.0k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

The transferrin receptor and the targeted delivery of therapeutic agents against cancer

2011 610 citations Tracy R. Daniels‐Wells, José A. Rodríguez et al. profile →
The transferrin receptor part I: Biology and targeting with cytotoxic antibodies for the treatment of cancer

2006 502 citations Tracy R. Daniels‐Wells, Tracie Delgado et al. Clinical Immunology profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Tracy R. Daniels‐Wells United States	26	1.5k	644	553	528	494	51	3.0k
Young Mo Kang South Korea	32	1.3k 0.9×	604 0.9×	534 1.0×	233 0.4×	719 1.5×	110	3.4k
Jun Qian China	28	1.9k 1.3×	577 0.9×	448 0.8×	214 0.4×	393 0.8×	113	3.5k
Manohar Ratnam United States	31	2.8k 1.9×	813 1.3×	1.1k 2.0×	452 0.9×	556 1.1×	103	5.5k
Tanyel Kiziltepe United States	30	2.3k 1.5×	1.2k 1.8×	648 1.2×	285 0.5×	331 0.7×	56	3.8k
In-San Kim South Korea	36	2.1k 1.4×	967 1.5×	535 1.0×	265 0.5×	554 1.1×	68	3.8k
Puja Sapra United States	28	1.5k 1.0×	787 1.2×	1.1k 2.1×	963 1.8×	400 0.8×	62	3.1k
Andreas Wicki Switzerland	27	1.8k 1.2×	1.1k 1.8×	1.5k 2.8×	308 0.6×	312 0.6×	81	4.6k
Jay S. Desgrosellier United States	19	2.7k 1.8×	416 0.6×	1.6k 2.9×	415 0.8×	759 1.5×	30	4.9k
Kathleen R. Whiteman United States	24	1.1k 0.7×	769 1.2×	1.0k 1.8×	787 1.5×	236 0.5×	45	2.5k
Mirco Ponzoni Italy	44	3.4k 2.3×	669 1.0×	1.2k 2.2×	337 0.6×	1.0k 2.0×	174	5.9k

Countries citing papers authored by Tracy R. Daniels‐Wells

Since Specialization

Citations

This map shows the geographic impact of Tracy R. Daniels‐Wells's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Tracy R. Daniels‐Wells with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Tracy R. Daniels‐Wells more than expected).

Fields of papers citing papers by Tracy R. Daniels‐Wells

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Tracy R. Daniels‐Wells. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Tracy R. Daniels‐Wells. The network helps show where Tracy R. Daniels‐Wells may publish in the future.

Co-authorship network of co-authors of Tracy R. Daniels‐Wells

This figure shows the co-authorship network connecting the top 25 collaborators of Tracy R. Daniels‐Wells. A scholar is included among the top collaborators of Tracy R. Daniels‐Wells based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Tracy R. Daniels‐Wells. Tracy R. Daniels‐Wells is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Guo, Beichu, et al.. (2025). Characterization of IgE cross-reactivity and allergenicity of peanut allergens. ImmunoHorizons. 9(7).

Daniels‐Wells, Tracy R., Pierre V. Candelaria, Á. Rodríguez, Marie‐Alix Poul, & Manuel L. Penichet. (2024). hu128.1, a humanized antibody targeting transferrin receptor 1, blocks erythroleukemia growth in xenograft mouse models. Haematologica. 110(5). 1187–1191. 1 indexed citations

Daniels‐Wells, Tracy R., Pierre V. Candelaria, Jing Wen, et al.. (2023). Efficacy of Antibodies Targeting TfR1 in Xenograft Mouse Models of AIDS-Related Non-Hodgkin Lymphoma. Cancers. 15(6). 1816–1816. 1 indexed citations

Candelaria, Pierre V., et al.. (2023). A Fully Human IgE Specific for CD38 as a Potential Therapy for Multiple Myeloma. Cancers. 15(18). 4533–4533. 4 indexed citations

Martínez, Laura E., Tracy R. Daniels‐Wells, Larry Magpantay, et al.. (2021). Targeting TfR1 with the ch128.1/IgG1 Antibody Inhibits EBV-driven Lymphomagenesis in Immunosuppressed Mice Bearing EBV+ Human Primary B-cells. Molecular Cancer Therapeutics. 20(9). 1592–1602. 4 indexed citations

Candelaria, Pierre V., Lai Sum Leoh, Manuel L. Penichet, & Tracy R. Daniels‐Wells. (2021). Antibodies Targeting the Transferrin Receptor 1 (TfR1) as Direct Anti-cancer Agents. Frontiers in Immunology. 12. 607692–607692. 154 indexed citations

Lurı́a-Pérez, Rosendo, Pierre V. Candelaria, Tracy R. Daniels‐Wells, et al.. (2019). Amino acid residues involved in the heparin-binding activity of murine IL-12 in the context of an antibody-cytokine fusion protein. Cytokine. 120. 220–226. 3 indexed citations

Leoh, Lai Sum, Yoon Kyung Kim, Pierre V. Candelaria, et al.. (2018). Efficacy and Mechanism of Antitumor Activity of an Antibody Targeting Transferrin Receptor 1 in Mouse Models of Human Multiple Myeloma. The Journal of Immunology. 200(10). 3485–3494. 21 indexed citations

Shi, Yijiang, Tracy R. Daniels‐Wells, Patrick Frost, et al.. (2016). Cytotoxic Properties of a DEPTOR-mTOR Inhibitor in Multiple Myeloma Cells. Cancer Research. 76(19). 5822–5831. 19 indexed citations

10.

Daniels‐Wells, Tracy R., et al.. (2015). Genetic Engineering of Antibody Molecules. 1. 1–52. 2 indexed citations

11.

Fu, Maoyong, Erin L. Maresh, Gustavo Helguera, et al.. (2014). Rationale and Preclinical Efficacy of a Novel Anti-EMP2 Antibody for the Treatment of Invasive Breast Cancer. Molecular Cancer Therapeutics. 13(4). 902–915. 41 indexed citations

12.

Daniels‐Wells, Tracy R., et al.. (2013). Iron in Multiple Myeloma. Critical Reviews™ in Oncogenesis. 18(5). 449–461. 20 indexed citations

13.

Daniels‐Wells, Tracy R., Richard K. Leuchter, Gustavo Helguera, et al.. (2011). Targeting HER2/neu with a fully human IgE to harness the allergic reaction against cancer cells. Cancer Immunology Immunotherapy. 61(7). 991–1003. 30 indexed citations

14.

Daniels‐Wells, Tracy R., Elizabeth Ortíz-Sánchez, Rosendo Lurı́a-Pérez, et al.. (2011). An Antibody-based Multifaceted Approach Targeting the Human Transferrin Receptor for the Treatment of B-cell Malignancies. Journal of Immunotherapy. 34(6). 500–508. 25 indexed citations

15.

Morizono, Kouki, Yiming Xie, Gustavo Helguera, et al.. (2009). A versatile targeting system with lentiviral vectors bearing the biotin‐adaptor peptide. The Journal of Gene Medicine. 11(8). 655–663. 43 indexed citations

16.

Karagiannis, Panagiotis, Josef Singer, James Hunt, et al.. (2008). Characterisation of an engineered trastuzumab IgE antibody and effector cell mechanisms targeting HER2/neu-positive tumour cells. Cancer Immunology Immunotherapy. 58(6). 915–930. 76 indexed citations

17.

Daniels‐Wells, Tracy R., Patrick P. Ng, Tracie Delgado, et al.. (2007). Conjugation of an anti–transferrin receptor IgG3-avidin fusion protein with biotinylated saporin results in significant enhancement of its cytotoxicity against malignant hematopoietic cells. Molecular Cancer Therapeutics. 6(11). 2995–3008. 32 indexed citations

18.

Daniels‐Wells, Tracy R., Tracie Delgado, José Antonio Rodríguez, Gustavo Helguera, & Manuel L. Penichet. (2006). The transferrin receptor part I: Biology and targeting with cytotoxic antibodies for the treatment of cancer. Clinical Immunology. 121(2). 144–158. 502 indexed citations breakdown →

19.

Daniels‐Wells, Tracy R., Tracie Delgado, Gustavo Helguera, & Manuel L. Penichet. (2006). The transferrin receptor part II: Targeted delivery of therapeutic agents into cancer cells. Clinical Immunology. 121(2). 159–176. 413 indexed citations

20.

Pacheco, Fabio J., Jacqueline A. Servin, David Dang, et al.. (2005). Involvement of lysosomal cathepsins in the cleavage of DNA topoisomerase I during necrotic cell death. Arthritis & Rheumatism. 52(7). 2133–2145. 27 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact